GSK's Eyes Benlysta Expansion With First US FDA Lupus Nephritis Approval

 
• By Jessica Merrill
LONDON- JUNE, 2018: The GlaxoSmithKline headquarters building in Brentford, west London. A British global pharmaceuticals company.
GSK has a new indication for Benlysta • Source: Shutterstock

More from Immunological

More from Therapeutic Category